PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape
AUAUniversity31 Mar 2021

PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape

This educational series is supported by independent educational grants from AstraZeneca and Merck. CME Available: https://auau.auanet.org/node/31198 Based on the documented need from the 2019 AUA global needs assessment in advanced prostate cancer, the AUA has produced a new series of educational offerings for the urologic care team focused on PARP inhibitors (PARPi). The first of three in the series PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape will address the latest developments in PARPi treatments and advanced prostate cancer care. Upon completion of this activity, participants will be able to: 1. Review recommended criteria for genetic testing of prostate cancer patients and the options for testing these men. 2. Explain importance of testing for germline pathogenic variants and their implication for utilizing novel targeted therapies such as PARP inhibitors and for cascade testing among patient family members. 3. Identify men with BRCA1/2 pathogenic variants and variants in other key inherited syndromes, regarding their prostate cancer and other cancer risk, and implement strategies for cancer screening and management.

Episoder(434)

Emerging Treatment of M0 CRPC: Update on the AUA/SUO Guidelines

Emerging Treatment of M0 CRPC: Update on the AUA/SUO Guidelines

Emerging Treatment of M0 CRPC: Update on the AUA/SUO Guidelines is the second podcast in a 4-part series. Topics will include “M0 CRPC: Emerging Treatment Options” and “MDC and Review of CRPC Guidelin...

30 Aug 201853min

AUA2018 Take Home Messages Basic Sciences - Trauma

AUA2018 Take Home Messages Basic Sciences - Trauma

AUA2018 Take Home Messages Basic Sciences - Trauma by American Urological Association

26 Aug 201821min

The Changing Landscape of Advanced Prostate Cancer Management: What You Need to Know

The Changing Landscape of Advanced Prostate Cancer Management: What You Need to Know

The Changing Landscape of Advanced Prostate Cancer Management: What You Need to Know is the first podcast in a 4-part series. Topics will include "Initial Management and Imaging of Advanced Prostate C...

21 Aug 201854min

AUA2018 043IC - Novel Agents and Concepts in the Management of Hormone Naïve

AUA2018 043IC - Novel Agents and Concepts in the Management of Hormone Naïve

This course will include short didactic lectures followed by case presentations to give attendees an understanding of the many new FDA-approved agents, as well as existing standard therapies, for adva...

16 Aug 20181h 36min

AUA2018 078IC - Management of Prostate Cancer: A Case Based Approach

AUA2018 078IC - Management of Prostate Cancer: A Case Based Approach

This course will provide a practical, evidence-based approach for the management of everyday problems in the management of prostate cancer, using a case-based approach with examples from real practice...

9 Aug 20182h 4min

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

The goal of the course is to provide both a basic and real-world application of immunotherapy for genitourinary oncology. The course is directed towards the urologist with an interest, but no prior ex...

1 Aug 20181h 55min

AUA2018 063IC - Prostate Cancer Update

AUA2018 063IC - Prostate Cancer Update

This course will offer a review of what faculty believe are the most important articles in the English-speaking literature on prostate cancer from May 2017 to April 2018. Focus will be placed on artic...

29 Jul 20181h 59min

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

Review of current chemotherapy and immunotherapy regimens for genitourinary malignancies, including bladder, renal, and prostate cancers. Indications, outcomes, and toxicities will be discussed as wel...

25 Jul 20181h 54min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
mikkels-paskenotter
foreldreradet
rss-strid-de-norske-borgerkrigene
treningspodden
rss-bisarr-historie
jakt-og-fiskepodden
takk-og-lov-med-anine-kierulf
sinnsyn
rss-sunn-okonomi
hverdagspsyken
tomprat-med-gunnar-tjomlid
gravid-uke-for-uke
fryktlos
rss-bak-luftfarten
ukast
lederskap-nhhs-podkast-om-ledelse
level-up-med-anniken-binz